BPCE
IMVT icon

Bank Pictet & Cie (Europe)’s Immunovant IMVT Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,089
Closed -$200K – 196
2024
Q4 		$200K Sell
8,089
-1,079
-12% -$30.6K ﹤0.01% 162
2024
Q3 		$261K Buy
+9,168
New +$270K 0.01% 138
2024
Q1 		– Sell
-5,512
Closed -$232K – 219
2023
Q4 		$232K Buy
+5,512
New +$203K 0.01% 247

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s IMVT Position: Q1 2025 in Review

Bank Pictet & Cie (Europe) sold out of Immunovant (IMVT) in Q1 2025, closing a stake of 8,089 shares — an estimated $200K sold.

Bank Pictet & Cie (Europe) first reported a position in IMVT in Q4 2023 and held it in 3 quarters. The position peaked at $261K in Q3 2024. 193 funds tracked by Wall St. Rank hold IMVT as of Q1 2025.

  • Bank Pictet & Cie (Europe) reported no remaining Immunovant position as of Q1 2025 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 8,089 Immunovant shares in Q1 2025, an estimated $200K.
  • Bank Pictet & Cie (Europe) first reported a position in Immunovant in Q4 2023 and held it in 3 quarters.
  • Bank Pictet & Cie (Europe)'s Immunovant position peaked at $261K in Q3 2024.
  • 193 funds tracked by Wall St. Rank held Immunovant as of Q1 2025.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2025, filed 17 Apr 2025.